×

EZH2 inhibitors for treating lymphoma

  • US 10,166,238 B2
  • Filed: 06/17/2015
  • Issued: 01/01/2019
  • Est. Priority Date: 06/17/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating non-Hodgkin'"'"'s lymphoma (NHL) comprising administering a therapeutically effective amount of an EZH2 inhibitor to a subject in need thereof, wherein the NHL is primary mediastinal large B-cell lymphoma (PMBCL), and wherein the EZH2 inhibitor is administered to the subject at a dose of about 100 mg to about 3200 mg daily.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×